Quantitative analysis for Vor Biopharma Inc. (VOR) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Buy (65.0) (grade B). 28 signals analyzed (23 differentiated alt-data).
VOR stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-28 | $14.66 | $13.97 | $14.38 |
| 2026-05-08 | $17.32 | $15.91 | $16.94 |
| 2026-05-20 | $15.61 | $14.20 | $15.55 |
| 2026-06-02 | $14.37 | $13.62 | $13.66 |
| 2026-06-12 | $14.83 | $14.07 | $14.36 |
| 2026-06-25 | $15.48 | $14.48 | $14.93 |
| 2026-07-08 | $20.36 | $19.05 | $20.31 |
| 2026-07-20 | $18.66 | $17.06 | $17.45 |
| 2026-07-30 | $21.90 | $19.59 | $21.80 |
| 2026-08-12 | $23.51 | $21.80 | $22.34 |
| 2026-08-24 | $23.17 | $21.90 | $22.71 |
| 2026-09-03 | $24.94 | $23.88 | $24.24 |
How Vor Biopharma Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ALXO | ALX Oncology Holdings Inc. | $108M | 52.0 |
| OWLT | Owlet, Inc. | $108M | — |
| NAKA | Nakamoto Inc. | $110M | — |
| GNLX | Genelux Corporation | $110M | — |
View all Health Care stocks by valuation and signals →
Vor Biopharma Inc. (VOR) scores Buy (65.0), with no measured dimension below 58. Its highest are competitive moat at 87, technicals at 73, across 3 measured dimensions. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 87 |
| technicals | 73 |
| analyst consensus | 58 |
StoQuant analyzes 28 signals (23 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Vor Biopharma Inc. (VOR): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/VOR"><img src="https://stoquant.com/badge/VOR.svg" alt="Vor Biopharma Inc. (VOR) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.